Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Avalo Therapeutics, a clinical stage biotechnology company, announced an inducement award of stock options to a new employee, approved under Nasdaq Listing Rule 5635(c)(4). The options grant 34,000 shares at an exercise price equal to the closing stock price of $16.60 per share, with a multi-year vesting schedule.